Ketamine Matches ‘Gold Standard’ in Major Depression Trial
SAN FRANCISCO — When it came to improving treatment-resistant major depression in outpatients without psychotic features, ketamine worked just as well as electroconvulsive therapy (ECT), the ELEKT-D randomized trial found. Following a 3-week treatment period, 55.4% of the patients in the ketamine group and 41.2% of those in the ECT group had a treatment response, […]
Is CBD Good for Schizophrenia?
Schizophrenia is a chronic psychotic disorder that affects a small portion of the world’s population. Symptoms typically manifest in early adulthood or late adolescence. Schizophrenia has several different symptoms, such as hallucinations and impaired brain functions. Although it is not a core symptom, people with schizophrenia also experience anxiety, and with the increasing popularity of […]